小智港美股早報 | 10月11日
最新行情
大公司頭條
遭分析師唱衰,福特、通用汽車攜手大跌。
醫藥檢測行業或現百億併購!傳Bio-Rad謀求與Qiagen合併。
默沙東肺動脈高壓新藥臨牀實驗有效。
幾乎召回所有上市汽車,Rivian連續兩日大跌近7%。
脫水研報
星展:維持美團-W(03690)“買入”評級 目標價296港元。
瑞信:維持騰訊(00700)“優於大市”評級 目標價升至441港元。
天風證券:維持李寧(02331)“買入”評級 大單品策略賦能產品矩陣。
華泰證券:維持金隅集團(02009)“買入”評級 目標價2.8港元。
海通證券:回顧歷史上港股見底背景 當前不必過度悲觀。
東吳證券:維持理想汽車-W(02015)“買入”評級 目標價133.4港元。
中信證券:維持阿裏巴巴-SW(09988)“買入”評級 目標價141港元。
中泰證券:維持藥明生物(02269)“買入”評級 看好CRDMO商業模式不斷兌現。
野村:維持藥明生物(02269)“買入”評級 目標價97.78港元。
富瑞:維持恆安國際(01044)“持有”評級 目標價降至37.7港元。
宏觀頭條
木頭姐致美聯儲公開信:未來最大的經濟風險是通縮而非通脹,美聯儲激進加息應受到質疑。
李迅雷:現在的位置,比2018年時更低,美聯儲加息或已近尾聲。
美聯儲副主席佈雷納德:就業市場出現一些再平衡的初步跡象。
諾貝爾經濟學獎授予美聯儲前主席伯南克等3位經濟學家。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.